- Email: [email protected]
Subject index to volume 44 (1981)
Journal oflmmunological Methods, 44 (1981) 369--371
369
Elsevier/North-Holland Biomedical Press
SUBJECT INDEX TO VOLUME 44 (1981) ABH group-specific substances detected as liposomes by HI test, 223--234 in human saliva by MASP, 115--123 Alloantigen in plasma vesicles fixed to cell membrane with PEG, 285--299 Antibodies affinity measured by quantitative IE, 271--284 anti-glycolipid, detected by liposome immune lysis, 153--158 anti-histone, detected by ELISA, 311--322 anti-parasite IgE and IgG, assayed by a solid-phase RIA, 101--114 anti-RBC cell-bound, quantitated with PAP by c y t o p h o t o m e t r y , 55---62 liposome-bound, haemolytic activity measured, 83--84 detection in circulating IC, methods reviewed, 263--264 monoclonal, to cell-surface Ag, screened by ELISA, 125--133 platelet, detected by EIA, 323--332 reaction with Ag on solid surfaces studies by an ellipsometric method, 343--349 Anticomplement immunoenzyme test (ACIE) detects EBNA in NPC cells, 73--78 Antigen cell-surface, bound to Ab-coated liposomes, 84 detection in circulating IC, methods reviewed, 263--264 rat transplantation, isolated from leukaemic cells, 23--35 Basophils, human, enriched by H-F sedimentation and glass-bead chromatography, 183--190 Blood collected safely from rabbit central ear artery, 241--245 Brugia malayi human antibodies quantitated by a solid-phase RIA, 101--114 Carboxyfluorescein as liposome label for immune lysis assay, 154--155 Cardiocytes, improved isolation for use as targets in cytotoxicity tests, 159--169 Catalase immunospecific binding protects cells from H202, 135--151 Chemotaxis distinguished from chemokinesis in granulocyte migration, 37--53 Collagenase treatment of viable cardiocytes for cytotoxicity tests, 160 Complement, human C1 q binding to circulating IC enhanced by PEG, 211--221 C3 split products detected by DD-RIE, 63--71 enzyme-labelled anti-C3 Ab in detecting EBNA, 73--78 Cytochalasin B dose-dependent effects on leukocyte migration, 44--48 Cytotoxicity, Ab-mediated, with viable cardiocytes as targets, 162--169 DEAE-Sepharose ion-exchange chromatography purifies myeloma IgM, 200--201 Electroimmunodiffusion quantitates lysozyme in human saliva, 15--21 Ellipsometry, diffusion-in-gel, detects bimolecular binding on solid surfaces, 343--349 Enzyme immunoassay (EIA) for platelet antibodies, 323--332 Enzyme-linked immunosorbent assay (ELISA) compared with RIA in detecting anti-parasite antibodies, 101--114 detects anti-histone antibodies in SLE sera, 311--322 for circulating IC, 87--100 0022-1759/81/0000-~3000/$02.50 © Elsevier/North-Holland Biomedical Press
370 for screening monoclonal antibodies, 323--332 measures helper activity in secondary antibody response, 301--310 Eosinophil non-specific staining in IF obliterated with DAB and H202, 191--198 Epstein-Barr virus nuclear antigen (EBNA) detected by ACIE, 73--78 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDCI) in IgG-liposome coupling, 80 Fetal calf serum (FCS) improves MH in detecting IgG, 2 3 6 , 2 3 9 Fibronectin, plasma and cellular, detected by a solid-phase RIA, 333--341 Fluorescein isothiocyanate (FITC) coupled to anti-human Ig Ab for tagging human B cells, 172--175 fl-Galactosidase coupled to anti-human IgG Ab for detecting platelet Ab, 324--325 Glass-bead chromatography in basophil enrichment, 186--187 Glycolipid antibodies detected by immune lysis of fluorochrome-liposomes, 153--158 Glycosphingolipid blood group determinants, liposomes prepared and tested, 223--234 Haemagglutination inhibition (HI} assay for listeria lipoteichoic acid, 351--357 by liposomes containing blood group-active glycosphingolipids, 230--232 Helper factor activity measured by ELISA, 301--310 Histocompatibility antigen, rat, solubilized, 23--35 Hypaque-Ficoll (H-F) sedimentation separates basophils from neutrophils, 185--186 IgG human, nanogram amounts measured by modified MH technique, 235--239 rabbit, attached to liposomes via EDCI, 80 IgM, human myeloma, isolated by a rapid procedure, 199--204 Immune complexes (IC) assayed with monoclonal R F and enzyme-labelled SpA, 87--100 C l q binding enhanced by PEG, 211--221 isolation and characterization methods reviewed, 249--269 Immunoelectrophoresis (IE) double-decker rocket {DD-RIE), assays C3 split products in plasma, 63--71 quantitative, measures relative antigen-antibody affinity, 271--284 tests purified human myeloma IgM, 202 Immunofluorescence (IF), eosinophil staining by FITC-anti-IgA Ab obliterated, 191--198 Immunoselection protects antigen-positive target cells, 135--151 Leukaemic cells, PVG rat, as source of major transplantation antigen, 23--35 Liposomes antibody-coated, bound to cell-surface antigen, 84 containing fluorochrome in measuring anti-glycolipid antibodies, 153--158 glycosphingolipids with blood group determinants, prepared and characterized, 223--234 coupled to IgG via EDCI, 80 Lipoteichoic acid quantitated by HI assay, 351--357 Listeria monocytogenes lipoteichoic acid assayed, 351--357 Lymphocytes human B, FITC-Ab-labelled, selected on anti-FITC Ab-coated dishes, 171--182 mitogen stimulation in serum-free system, 3--14 rat, Ag-induced proliferation in vitro, optimal culture conditions, 205--209 Lysozyme, human submandibular-sublingual, detected by electroimmunodiffusion, 15--21
371 m-Maleimidobenzoyl-hydroxysuccinimide in coupling IgG to ~-galactosidase, 325 2-Mercaptoethanol needed for optimal Ag-induced lymphoproliferation, 207--208 Microphotometry, absorption, measures PAP reaction product on single cells, 55--62 Mitogen stimulation of lymphocytes in serum-free media, 3--14 Mixed agglutination in solid phase (MASP) detects soluble ABH antigens, 115--123 haemadsorption (MH) measures low IgG levels using media with FCS, 235--239 Nasopharyngeal carcinoma (NPC) cells examined for EBNA by ACIE, 73--78 Neutrophils, human migration under agarose studies, 37--53 separated from basophils by H-F sedimentation, 185--186 Papain solubilizes rat transplantation antigen from leukaemic cells, 25--26 Peroxidase antiperoxidase (PAP) reaction measured on single cells by c y t o p h o t o m e t r y , 55--62 labelled anti-C3 Ab in detecting EBNA, 73--78 SpA in ELISA for circulating IC, 88--100 Plasma vesicles with alloantigen fixed to cell membrane by PEG, 285--299 Platelet antibodies detected in human sera by EIA, 323--332 Polyethylene glycol (PEG) enhances C l q binding to circulating IC, 211--221 fixes vesicles with alloantigen to cell membrane, 285--299 Rabbits bled safely from central ear artery, 241--245 Radioimmunoassay (RIA) for human fibronectin, 333--341 superior to ELISA in detecting anti-parasite Ab, 101--114 Rheumatoid factor (RF), monoclonal, in ELISA for circulating IC, 87--100 Serum free media in mitogen stimulation of lymphocytes, 3--14 syngeneic, needed for optimal Ag-induced lymphoproliferation, 207--208 Staphylococcal protein A (SPA) enzyme-labelled, in ELISA for circulating IC, 88--100 in isolation of circulating IC, 254--255 3,4,3 ,4-Tetraammoblphenylhydrochlorlde (DAB) and H202 obliterate non-specific staining of eosinophils in IF, 191--198 p
t
.
.
.
Ultrogel AcA filtration in isolating human myeloma IgM, 200--201
369
Elsevier/North-Holland Biomedical Press
SUBJECT INDEX TO VOLUME 44 (1981) ABH group-specific substances detected as liposomes by HI test, 223--234 in human saliva by MASP, 115--123 Alloantigen in plasma vesicles fixed to cell membrane with PEG, 285--299 Antibodies affinity measured by quantitative IE, 271--284 anti-glycolipid, detected by liposome immune lysis, 153--158 anti-histone, detected by ELISA, 311--322 anti-parasite IgE and IgG, assayed by a solid-phase RIA, 101--114 anti-RBC cell-bound, quantitated with PAP by c y t o p h o t o m e t r y , 55---62 liposome-bound, haemolytic activity measured, 83--84 detection in circulating IC, methods reviewed, 263--264 monoclonal, to cell-surface Ag, screened by ELISA, 125--133 platelet, detected by EIA, 323--332 reaction with Ag on solid surfaces studies by an ellipsometric method, 343--349 Anticomplement immunoenzyme test (ACIE) detects EBNA in NPC cells, 73--78 Antigen cell-surface, bound to Ab-coated liposomes, 84 detection in circulating IC, methods reviewed, 263--264 rat transplantation, isolated from leukaemic cells, 23--35 Basophils, human, enriched by H-F sedimentation and glass-bead chromatography, 183--190 Blood collected safely from rabbit central ear artery, 241--245 Brugia malayi human antibodies quantitated by a solid-phase RIA, 101--114 Carboxyfluorescein as liposome label for immune lysis assay, 154--155 Cardiocytes, improved isolation for use as targets in cytotoxicity tests, 159--169 Catalase immunospecific binding protects cells from H202, 135--151 Chemotaxis distinguished from chemokinesis in granulocyte migration, 37--53 Collagenase treatment of viable cardiocytes for cytotoxicity tests, 160 Complement, human C1 q binding to circulating IC enhanced by PEG, 211--221 C3 split products detected by DD-RIE, 63--71 enzyme-labelled anti-C3 Ab in detecting EBNA, 73--78 Cytochalasin B dose-dependent effects on leukocyte migration, 44--48 Cytotoxicity, Ab-mediated, with viable cardiocytes as targets, 162--169 DEAE-Sepharose ion-exchange chromatography purifies myeloma IgM, 200--201 Electroimmunodiffusion quantitates lysozyme in human saliva, 15--21 Ellipsometry, diffusion-in-gel, detects bimolecular binding on solid surfaces, 343--349 Enzyme immunoassay (EIA) for platelet antibodies, 323--332 Enzyme-linked immunosorbent assay (ELISA) compared with RIA in detecting anti-parasite antibodies, 101--114 detects anti-histone antibodies in SLE sera, 311--322 for circulating IC, 87--100 0022-1759/81/0000-~3000/$02.50 © Elsevier/North-Holland Biomedical Press
370 for screening monoclonal antibodies, 323--332 measures helper activity in secondary antibody response, 301--310 Eosinophil non-specific staining in IF obliterated with DAB and H202, 191--198 Epstein-Barr virus nuclear antigen (EBNA) detected by ACIE, 73--78 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDCI) in IgG-liposome coupling, 80 Fetal calf serum (FCS) improves MH in detecting IgG, 2 3 6 , 2 3 9 Fibronectin, plasma and cellular, detected by a solid-phase RIA, 333--341 Fluorescein isothiocyanate (FITC) coupled to anti-human Ig Ab for tagging human B cells, 172--175 fl-Galactosidase coupled to anti-human IgG Ab for detecting platelet Ab, 324--325 Glass-bead chromatography in basophil enrichment, 186--187 Glycolipid antibodies detected by immune lysis of fluorochrome-liposomes, 153--158 Glycosphingolipid blood group determinants, liposomes prepared and tested, 223--234 Haemagglutination inhibition (HI} assay for listeria lipoteichoic acid, 351--357 by liposomes containing blood group-active glycosphingolipids, 230--232 Helper factor activity measured by ELISA, 301--310 Histocompatibility antigen, rat, solubilized, 23--35 Hypaque-Ficoll (H-F) sedimentation separates basophils from neutrophils, 185--186 IgG human, nanogram amounts measured by modified MH technique, 235--239 rabbit, attached to liposomes via EDCI, 80 IgM, human myeloma, isolated by a rapid procedure, 199--204 Immune complexes (IC) assayed with monoclonal R F and enzyme-labelled SpA, 87--100 C l q binding enhanced by PEG, 211--221 isolation and characterization methods reviewed, 249--269 Immunoelectrophoresis (IE) double-decker rocket {DD-RIE), assays C3 split products in plasma, 63--71 quantitative, measures relative antigen-antibody affinity, 271--284 tests purified human myeloma IgM, 202 Immunofluorescence (IF), eosinophil staining by FITC-anti-IgA Ab obliterated, 191--198 Immunoselection protects antigen-positive target cells, 135--151 Leukaemic cells, PVG rat, as source of major transplantation antigen, 23--35 Liposomes antibody-coated, bound to cell-surface antigen, 84 containing fluorochrome in measuring anti-glycolipid antibodies, 153--158 glycosphingolipids with blood group determinants, prepared and characterized, 223--234 coupled to IgG via EDCI, 80 Lipoteichoic acid quantitated by HI assay, 351--357 Listeria monocytogenes lipoteichoic acid assayed, 351--357 Lymphocytes human B, FITC-Ab-labelled, selected on anti-FITC Ab-coated dishes, 171--182 mitogen stimulation in serum-free system, 3--14 rat, Ag-induced proliferation in vitro, optimal culture conditions, 205--209 Lysozyme, human submandibular-sublingual, detected by electroimmunodiffusion, 15--21
371 m-Maleimidobenzoyl-hydroxysuccinimide in coupling IgG to ~-galactosidase, 325 2-Mercaptoethanol needed for optimal Ag-induced lymphoproliferation, 207--208 Microphotometry, absorption, measures PAP reaction product on single cells, 55--62 Mitogen stimulation of lymphocytes in serum-free media, 3--14 Mixed agglutination in solid phase (MASP) detects soluble ABH antigens, 115--123 haemadsorption (MH) measures low IgG levels using media with FCS, 235--239 Nasopharyngeal carcinoma (NPC) cells examined for EBNA by ACIE, 73--78 Neutrophils, human migration under agarose studies, 37--53 separated from basophils by H-F sedimentation, 185--186 Papain solubilizes rat transplantation antigen from leukaemic cells, 25--26 Peroxidase antiperoxidase (PAP) reaction measured on single cells by c y t o p h o t o m e t r y , 55--62 labelled anti-C3 Ab in detecting EBNA, 73--78 SpA in ELISA for circulating IC, 88--100 Plasma vesicles with alloantigen fixed to cell membrane by PEG, 285--299 Platelet antibodies detected in human sera by EIA, 323--332 Polyethylene glycol (PEG) enhances C l q binding to circulating IC, 211--221 fixes vesicles with alloantigen to cell membrane, 285--299 Rabbits bled safely from central ear artery, 241--245 Radioimmunoassay (RIA) for human fibronectin, 333--341 superior to ELISA in detecting anti-parasite Ab, 101--114 Rheumatoid factor (RF), monoclonal, in ELISA for circulating IC, 87--100 Serum free media in mitogen stimulation of lymphocytes, 3--14 syngeneic, needed for optimal Ag-induced lymphoproliferation, 207--208 Staphylococcal protein A (SPA) enzyme-labelled, in ELISA for circulating IC, 88--100 in isolation of circulating IC, 254--255 3,4,3 ,4-Tetraammoblphenylhydrochlorlde (DAB) and H202 obliterate non-specific staining of eosinophils in IF, 191--198 p
t
.
.
.
Ultrogel AcA filtration in isolating human myeloma IgM, 200--201